Issue link: https://viewer.e-digitaledition.com/i/618504
FUNDING IS A CRUCIAL COMPONENT TO FURTHERING MEDICAL RESEARCH RELATED TO DOWN SYNDROME. THAT'S WHY THE GLOBAL DOWN SYNDROME FOUNDATION CONTINUES TO PURSUE AND SUPPORT PASSING THE 21ST CENTURY CURES ACT. 21st Century Cures Advancing Medical Research THE BIPARTISAN LEGISLATION, sponsored by Rep. Diana DeGette (D-CO) and Rep. Fred Upton (R-MI), is aimed at accelerating the pace of cures and medical breakthroughs in the United States — a move that could positively impact the lives of people who have Down syndrome. "By investing nearly $9 billion in new biomedical research at the National Institutes of Health (NIH) and modernizing the U.S. Food and Drug Administration (FDA) drug approval process, 21st Century Cures will bring hope to millions of families, including those families whose loved ones with Down syndrome may suffer from a myriad of diseases," Rep. DeGette said. "We owe it to these families to break the mold on research and development and open the doors to the next century of biomedical innovation." The bill passed in the House of Representatives in July 2015 by an overwhelming majority — 344 to 77. The Senate equivalent to 21st Century Cures, called "Innovation for Healthier Americans," has yet to come to a vote. If it becomes law, the 21st Century Cures Act will boost the NIH's research budget by $1.75 billion annually for the next five years. The extra money would not only keep the U.S. at the forefront of biomedical science worldwide but also infuse universities and research organizations with resources needed to investigate the connections between Down syndrome and many of the diseases and conditions that people with Down syndrome are either protected from (e.g. heart attack and stroke) or predisposed to (e.g. Alzheimer's disease and autoimmune disorders). Currently, Down syndrome is one of the least funded genetic conditions by the NIH. WHAT IT MEANS The 21st Century Cures Act would streamline existing regulations and requirements that slow research and, subsequently, the availability of new treatments. Specifically, the Act would modernize the drug trial and approval process by removing restrictions that prohibit researchers from sharing data, allow drug developers to incorporate patient experiences into drug evaluations rather than relying solely on expensive randomized controlled trials, and give the FDA the ability to expedite the approval of breakthrough therapies and technologies for life-threatening conditions, provided those approvals meet stringent safety regulations. From a research perspective, 21st Century Cures would allow the NIH to improve and speed up its grant application process and make it easier for young and emerging scientists to get funding for their research proposals. The last few years of stagnant NIH funding has inadvertently led to an emphasis on senior scientists and has meant promising young scientists must often wait years or even a decade for their first grant, prompting many to leave their fields. FOLLOW THE BILL ONLINE using hashtags #Path2Cures and #Cures2015 on Facebook and Twitter. Read more about Innovation for Healthier Americans from Sen. Lamar Alexander and Sen. Richard Burr: bit.ly/Global-IHA FALL2015 DOWN SYNDROME WORLD 6

